Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project

International Journal of Epidemiology

Volumn 40, Issue 6, 2011, Pages 1667-

  Bjørge, Tone ^a,b   Lukanova, Annekatrin ^c   Tretli, Steinar ^d   Manjer, Jonas ^e   Ulmer, Hanno ^f   Stocks, Tanja ^g   Selmer, Randi ^b   Nagel, Gabriele ^h   Almquist, Martin ^e   Concin, Hans ⁱ   Hallmans, Göran ^g   Jonsson, Håkan ^g   Häggström, Christel ^g   Stattin, Pär ^g   Engeland, Anders ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g UMEÅ UNIVERSITY   (Sweden)

^h UNIVERSITY OF ULM   (Germany)

ⁱ AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

Author keywords

Cohort study; Conor; Incidence; Metabolic syndrome; Mortality; Ovarian cancer

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

AGE CLASS; BLOOD SYSTEM DISORDER; CANCER; COHORT ANALYSIS; DISEASE INCIDENCE; HEALTH RISK; MORTALITY; TUMOR;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRIA; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MUCINOUS CARCINOMA; NORWAY; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; FEMALE; HUMANS; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

AUSTRIA; NORWAY; SWEDEN;

EID: 84855340916     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyr130     Document Type: Article

References (39)

1. Boyle P, Levin B. World Cancer Report 2008. International Agency for Research on Cancer, Lyon, France, 2008.
2. Kotsopoulos J, Baer HJ, Tworoger SS. Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study. Obesity 2010;18:1625-31.
3. Lahmann PH, Cust AE, Friedenreich CM et al. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010;126:2404-15.
4. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension 1999;34:320-25.
5. Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiology, Biomarkers and Prevention 2005;14:98-107.
6. Stocks T, Borena W, Strohmaier S et al. Cohort profile: the Metabolic Syndrome and Cancer project (Me-Can). Int J Epidemiol 2009;39:660-67.
7. Bjørge T, Lukanova A, Jonsson H et al. Metabolic syndrome and breast cancer in the Me-Can (Metabolic Syndrome and Cancer) project. Cancer Epidemiol Biomarkers Prev 2010;19:1737-45.
8. Bjørge T, Stocks T, Lukanova A et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010;171: 892-902.
9. Lee KR, Tavassoli FA, Prat J et al. Tumours of the ovary and peritoneum. Surface epithelial-stromal tumours. In: Tavassoli FA, Devilee P (eds). Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003, pp. 117-45.
10. Eurostat, European shortlist for causes of death, 1998. http://ec.europa.eu/eurostat/ramon/nomenclatures/index.cfm?TargetUrl=LST_NOM_DTL&StrNom=COD_1998. 2009. 10 August 2011, date last accessed.
11. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall Ltd, 1984, pp. 1-201.
12. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903-13.
13. Stocks T, Rapp K, Bjørge T et al. Blood glucose and risk of incident and fatal cancer in the Metabolic Syndrome and Cancer project (Me-Can): analysis of six prospective cohorts. PLoS Med 2009;6:e1000201.
14. Wood AM, White I, Thompson SG, Lewington S, Danesh J. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 2006;35:1570-8.
15. Fibrinogen Studies Collaboration. Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Stat Med 2009; 28:1067-92.
16. Clarke R, Shipley M, Lewington S et al. Underestimation of risk associations due to regression dilution in longterm follow-up of prospective studies. Am J Epidemiol 1999;150:341-53.
17. Emberson JR, Whincup PH, Morris RW, Walker M, Lowe GD, Rumley A. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil 2004;11:125-34.
18. Whitlock G, Clark T, Vander HS et al. Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol 2001;17:907-9.
19. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27-33.
20. Larsen IK, Småstuen M, Johannesen TB et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-31.
21. Rapp K, Schroeder J, Klenk J et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006;49:945-52.
22. Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 2008;7:17.
23. Franks PW, Ekelund U, Brage S, Wong MY, Wareham NJ. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness? Diabetes Care 2004;27: 1187-93.
24. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-304.
25. Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
26. Kahn R. Metabolic syndrome-What is the clinical usefulness? Lancet 2008;371:1892-3.
27. Stocks T, Lukanova A, Johansson M et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obesity 2008;32:304-14.
28. Unwin N. The metabolic syndrome. J R Soc Med 2006;99: 457-62.
29. Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003;95:1244-48.
30. Schouten LJ, Rivera C, Hunter DJ et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol, Biomarkers Prev 2008;17: 902-12.
31. Strasak AM, Pfeiffer RM, Brant LJ et al. Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study. Ann Oncol 2009;20: 1113-20.
32. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 2002;13:417-26.
33. Törnberg SA, Holm LE, Carstensen JM, Eklund GA. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med 1986;315: 1629-33.
34. Hemminki K, Li X, Sundquist J, Sundquist K. Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010;15:548-55.
35. Kellenberger LD, Bruin JE, Greenaway J et al. The role of dysregulated glucose metabolism in epithelial ovarian cancer. J Oncol 2010;2010: doi:10.1155/2010/514310 [Epub 17 February 2010].
36. Lund HL, Wisloff TF, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006;164:769-74.
37. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687-95.
38. McTiernan A, Irwin M, Vongruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 2010;28:4074-80.
39. Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 2001; 60:81-89.